Sana Biotechnology, Inc. Profile Avatar - Palmy Investing

Sana Biotechnology, Inc.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabe…

Biotechnology
US, Seattle [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Sana Biotechnology, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of SANA's Analysis
CIK: 1770121 CUSIP: 799566104 ISIN: US7995661045 LEI: - UEI: -
Secondary Listings
SANA has no secondary listings inside our databases.